COX-2 is a novel target in therapy of mycosis fungoides

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

COX-2 is a novel target in therapy of mycosis fungoides. / Kopp, K L M; Dabelsteen, S; Krejsgaard, T; Eriksen, K W; Geisler, Carsten; Becker, J C; Wasik, M; Ødum, N; Danielsen, Alex Le Woetmann.

In: Leukemia, Vol. 24, No. 12, 01.12.2010, p. 2127-9.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kopp, KLM, Dabelsteen, S, Krejsgaard, T, Eriksen, KW, Geisler, C, Becker, JC, Wasik, M, Ødum, N & Danielsen, ALW 2010, 'COX-2 is a novel target in therapy of mycosis fungoides', Leukemia, vol. 24, no. 12, pp. 2127-9. https://doi.org/10.1038/leu.2010.221

APA

Kopp, K. L. M., Dabelsteen, S., Krejsgaard, T., Eriksen, K. W., Geisler, C., Becker, J. C., Wasik, M., Ødum, N., & Danielsen, A. L. W. (2010). COX-2 is a novel target in therapy of mycosis fungoides. Leukemia, 24(12), 2127-9. https://doi.org/10.1038/leu.2010.221

Vancouver

Kopp KLM, Dabelsteen S, Krejsgaard T, Eriksen KW, Geisler C, Becker JC et al. COX-2 is a novel target in therapy of mycosis fungoides. Leukemia. 2010 Dec 1;24(12):2127-9. https://doi.org/10.1038/leu.2010.221

Author

Kopp, K L M ; Dabelsteen, S ; Krejsgaard, T ; Eriksen, K W ; Geisler, Carsten ; Becker, J C ; Wasik, M ; Ødum, N ; Danielsen, Alex Le Woetmann. / COX-2 is a novel target in therapy of mycosis fungoides. In: Leukemia. 2010 ; Vol. 24, No. 12. pp. 2127-9.

Bibtex

@article{755bfc93d1ff494cb1db44c2acf4c20c,
title = "COX-2 is a novel target in therapy of mycosis fungoides",
keywords = "Animals, Cell Line, Tumor, Cyclooxygenase 2 Inhibitors, Humans, Ki-67 Antigen, Mice, Mycosis Fungoides, Pyrazoles, Skin Neoplasms, Sulfonamides, Xenograft Model Antitumor Assays",
author = "Kopp, {K L M} and S Dabelsteen and T Krejsgaard and Eriksen, {K W} and Carsten Geisler and Becker, {J C} and M Wasik and N {\O}dum and Danielsen, {Alex Le Woetmann}",
year = "2010",
month = dec,
day = "1",
doi = "10.1038/leu.2010.221",
language = "English",
volume = "24",
pages = "2127--9",
journal = "Leukemia",
issn = "0887-6924",
publisher = "nature publishing group",
number = "12",

}

RIS

TY - JOUR

T1 - COX-2 is a novel target in therapy of mycosis fungoides

AU - Kopp, K L M

AU - Dabelsteen, S

AU - Krejsgaard, T

AU - Eriksen, K W

AU - Geisler, Carsten

AU - Becker, J C

AU - Wasik, M

AU - Ødum, N

AU - Danielsen, Alex Le Woetmann

PY - 2010/12/1

Y1 - 2010/12/1

KW - Animals

KW - Cell Line, Tumor

KW - Cyclooxygenase 2 Inhibitors

KW - Humans

KW - Ki-67 Antigen

KW - Mice

KW - Mycosis Fungoides

KW - Pyrazoles

KW - Skin Neoplasms

KW - Sulfonamides

KW - Xenograft Model Antitumor Assays

U2 - 10.1038/leu.2010.221

DO - 10.1038/leu.2010.221

M3 - Journal article

C2 - 20882047

VL - 24

SP - 2127

EP - 2129

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 12

ER -

ID: 33732474